Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
SourceAutoimmunity Reviews, 19, 11, (2020), article 102671
Article / Letter to editor
Display more detailsDisplay less details
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 11: Renal disorders RIHS: Radboud Institute for Health Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.